2-Quinoxalinecarboxylic acid, 7-[4-[[[[(4-carboxyphenyl)amino]carbonyl]oxy]methyl]-1H-imidazol-1-yl]-3,4-dihydro-3-oxo-6-(trifluoromethyl)- manufacturers
- KRP-199
-
- $1670.00
-
2026-05-11
- CAS:221164-28-9
- Purity:
- Supply Ability: 10g
|
| | 2-Quinoxalinecarboxylic acid, 7-[4-[[[[(4-carboxyphenyl)amino]carbonyl]oxy]methyl]-1H-imidazol-1-yl]-3,4-dihydro-3-oxo-6-(trifluoromethyl)- Basic information |
| | 2-Quinoxalinecarboxylic acid, 7-[4-[[[[(4-carboxyphenyl)amino]carbonyl]oxy]methyl]-1H-imidazol-1-yl]-3,4-dihydro-3-oxo-6-(trifluoromethyl)- Chemical Properties |
| Melting point | 278-280 °C (decomp) | | density | 1.69±0.1 g/cm3(Predicted) | | pka | 0.09±0.20(Predicted) |
| | 2-Quinoxalinecarboxylic acid, 7-[4-[[[[(4-carboxyphenyl)amino]carbonyl]oxy]methyl]-1H-imidazol-1-yl]-3,4-dihydro-3-oxo-6-(trifluoromethyl)- Usage And Synthesis |
| Uses | KRP-199 (compound 14h) is an α-amino-3-hydroxy-5-methylisoxazolepropionic acid receptor (AMPA-R) antagonist (Ki=16 nM) with high potency and selectivity for AMPA-R in vitro and good neuroprotective effects in vivo. KRP-199 can be used in the study of neurodegenerative diseases[1]. | | References | [1] Takano, et al. Design and synthesis of novel 7-heterocycle-6-trifluoromethyl-3-oxoquinoxaline-2-carboxylic acids bearing a substituted phenyl group as superior AMPA receptor antagonists with good physicochemical properties. Bioorganic & medicinal chemistry 14.3 (2006): 776-792. DOI:10.1016/j.bmc.2005.08.060 |
| | 2-Quinoxalinecarboxylic acid, 7-[4-[[[[(4-carboxyphenyl)amino]carbonyl]oxy]methyl]-1H-imidazol-1-yl]-3,4-dihydro-3-oxo-6-(trifluoromethyl)- Preparation Products And Raw materials |
|